How advanced flow cytometry could transform cell and gene therapy

Cell and gene therapy is an extremely promising area of biomedical research, with many breakthroughs in treatments that target genetic disorders and cancer. Although this area has seen rapid growth, companies encounter technical challenges and high costs regarding the phenotyping and profiling of cell products.

This article focuses on the role of flow cytometry in developing chimeric antigen receptor (CAR) T cells and how advanced systems may enhance workflows and facilitate bringing new therapies to the bedside.